将“财健道”设为星标持续关注,不错过好看每日医刻1创新药IND审批时限缩短至30日6月16日,国家药监局发布《关于优化创新药临床试验审评审批有关事项的公告(征求意见稿)》提到,为进一步支持以临床价值为导向的创新药研发,提高临床研发质效,对符合要求的创新药临床试验申请在30个工作日内完成审评审批。不过,目前并非所有创新药都能走这快速通道。意见稿中提出,纳入这一通道的应当为中药、化学药品、生物制品1类...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.